Warren Buffett
Berkshire Hathaway
Warren Buffett DaVita HealthCare Partners Inc stake
total: 135
Berkshire Hathaway DVA trades
- Total transactions:
- 13
- New positions:
- 1
- Added:
- 4
- Reduced:
- 8
- Held since:
- 2013 Q2 or earlier
- Held for:
- 53+ quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Warren Buffett holds 28,880,209 DaVita HealthCare Partners Inc (DVA) shares with a market value of roughly $6.43B accounting for 2.15% of the overall portfolio. Berkshire Hathaway has held DVA since at least 2013 Q2 with about 29.95M shares in our earliest available record. Since at least 2013 Q2, Berkshire Hathaway has made 12 more transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $61.28
- Weighted AVG sell price:
- $137.73
Warren Buffett's historical trades in DaVita HealthCare Partners Inc
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.15%
|
28,880,209
|
$222.48
|
$6,425,268,898
|
-4.05% (-1,220,376)
|
-0.1%
|
|
2026 Q1
|
1.76%
|
30,100,585
|
$153.69
|
$4,626,158,909
|
-5.22% (-1,658,480)
|
-0.09%
|
|
2025 Q4
|
1.32%
|
31,759,065
|
$113.61
|
$3,608,147,375
|
-1.25% (-401,514)
|
-0.02%
|
|
2025 Q3
|
1.60%
|
32,160,579
|
$132.87
|
$4,273,176,132
|
-4.84% (-1,635,962)
|
-0.08%
|
|
2025 Q2
|
1.87%
|
33,796,541
|
$142.45
|
$4,814,317,266
|
-3.83% (-1,345,938)
|
-0.07%
|
|
2025 Q1
|
2.07%
|
35,142,479
|
$152.97
|
$5,375,745,012
|
-2.64% (-953,091)
|
-0.05%
|
|
2020 Q3
|
1.31%
|
$85.65
|
-5.25% (-2,000,000)
|
|||
|
2020 Q1
|
1.65%
|
$76.06
|
-1.22% (-470,000)
|
|||
|
2014 Q4
|
2.67%
|
$75.74
|
+2.51% (+944,418)
|
|||
|
2014 Q1
|
2.45%
|
$68.85
|
+3.18% (+1,159,858)
|
|||
|
2013 Q4
|
2.20%
|
$63.37
|
+15.95% (+5,014,464)
|
|||
|
2013 Q3
|
1.94%
|
$56.90
|
+5.01% (+1,499,018)
|
|||
|
2013 Q2
|
1.97%
|
$60.40
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.